2-Bromopyrimidine-4-carboxylic acid, 95.0%, 100mg

(4E)-4-(ethoxymethylene)-2-phenyl-1,3-oxazol-5(4H)-one, 5g

(R)-1-(4-Bromothiophen-2-yl)ethanol, 98+%, 2.5g

1,2-Bis(m-tolyloxy)ethane, 97%, 1g

5,7-Dihydroxy-2,2-dimethyl-4H-1,3-benzodioxin-4-one, 95.0%, 5g

HPLC column NUCLEODUR® C18 Gravity 5 µm, 250 mm, 4.6 mm, 1 Piece(s)

4-chloro-2-methyl-3-propylquinoline-6-carboxylic acid, 95.0%, 250mg

3-(4-Methoxyphenyl)pyrazole-4-carboxaldehyde>98.0%(GC)5g

1,3-Bis(4,5-dihydrooxazol-2-yl)benzene, 95.0%, 100g

1,2,4-Tribromobenzene, 95.0%, 25g

VidofludiMus, 1mg

2-Amino-1,7-dihydro-6H-purine-6-thione, 95.0%, 25g

2-[3,5-dimethyl-1-(2,2,2-trifluoroethyl)-1h-pyrazol-4-yl]acetic acid, 95%, 2.5g